IVORY A PHASE III OPEN LABEL, RANDOMIZED, 2 ARM STUDY OF IXABEPILONE ADMINISTERED EVERY 21 DAYS VERSUS PACLITAXEL OR DOXORUBICIN ADMINISTERED EVERY 21 DAYS IN WOMEN WITH ADVANCED ENDOMETRIAL CANCER WHO HAVE PREVIOUSLY BEEN TREATED WITH CHEMOTHERAPY Trademark 77762649

Trademark: 77762649

Word

IVORY A PHASE III OPEN LABEL, RANDOMIZED, 2 ARM STUDY OF IXABEPILONE ADMINISTERED EVERY 21 DAYS VERSUS PACLITAXEL OR DOXORUBICIN ADMINISTERED EVERY 21 DAYS IN WOMEN WITH ADVANCED ENDOMETRIAL CANCER WHO HAVE PREVIOUSLY BEEN TREATED WITH CHEMOTHERAPY

Status

Pending

Status Code

622

Status Date

Wednesday, June 24, 2009

Serial Number

77762649

Mark Type

4000

Trademark Owner History

Bristol-Myers Squibb Company

Classifications

42 Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use

Trademark Events

Dec 17, 2009

Attorney Revoked And/Or Appointed

Dec 17, 2009

Teas Revoke/Appoint Attorney Received

Jun 22, 2009

New Application Entered In Tram

77762648

SGG MASTER-CARRÉ

Trademark Alertz updated from USPTO on 2030-01-24